Q: Second question today, I took about a 3% position in this stock for a long term hold, far from the top but still down significantly. March has been volatile and really trending down in recent days. I cannot see any negative news but with earnings coming out on Monday is this a bad news indication or just market impact? Do you continue to like the company's growth prospects? Thank you.
Q: I have reviewed these two ETF for Healthcare sector allocation using CDN funds and wonder what 5i’s preference would be between the two and why your preference. My Healthcare sector currently is made up with small caps GUD and WELL and the 13% or so of VFV and VIG ETFs
DOC has been taking it on the chin over the last month or two. Is there anything going on here? Would this be an opportunity to average down? Would you initiate a new position at this time?
Q: I am looking to add 1 or 2 U. S. Healthcare companies to my U. S. cash account. Of the 4 above could you list them in order from best to worst with a comment on thier financial and growth situation. Please include any other choices that you might add to my list.
Much appreciated.
John
Q: Hi, Do you have an opinion on Bio-Techne? Would this be a good candidate for some healthcare gowth? Would you suggest a nother name for the Biotechnology industry? I thank-you in advance.Sam
Q: My question is on WELL’s recent earnings report. With a revenue run rate of $300M, doesn’t this give WELL a forward-looking P/S ratio of less than 5? This sounds incredibly cheap for a high-growth, small cap company. What am I missing? Trailing revenue run rate was only $50M. Has the big jump in revenue already been priced in?
Q: After the recent 6 mil share offering at $5 , can you determine how many Class A shares are now outstanding and how much are controlled by insiders? Thanks
Could you please suggest a couple ideas for tech and health care exposure within a TFSA. I hear there are advantages/disadvantages of different type of ETFs.
Thanks